NCI

Forecast & Rating14 analysts currently cover NCI, with about 57.1% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥65.65, about 4.7% upside from the current price of ¥62.71. Price targets range from ¥38.60 to ¥85.00 — a wide spread, showing clear disagreement over just how much NCI can rise. Historically, about 69.2% of past price targets were eventually met, which adds credibility. For you, this means institutional views on NCI are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 22, 2026; for reference only and not investment advice.